Literature DB >> 22009935

Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors.

Qingyan Zhang1, Caihong Zeng, Zhen Cheng, Kenan Xie, Jiong Zhang, Zhihong Liu.   

Abstract

BACKGROUND: Focal segmental glomerulosclerosis (FSGS) presents a range of potentially serious complications, including acute kidney injury (AKI), infection and thromboembolism. This study aimed to find out the incidence rates and risk factors for these complications in FSGS patients.
METHODS: Patients with biopsy-proven primary FSGS and nephrotic-range proteinuria were included in this study. A short-term (16-week) follow-up was performed to observe the aforementioned complications. Clinical characteristics of patients were recorded upon enrollment. AKI was diagnosed as an absolute increase in serum creatinine of ≥0.3 mg/dL or a percentage increase of ≥50% within 48 hours; infection, by a combination of clinical manifestations, laboratory tests and imaging examinations; and thromboembolism, by imaging methods. Risk factors for complications were evaluated by logistic regression model.
RESULTS: The study population included 90 FSGS patients (63 males, mean age 28.9 ± 12.9 years). The incidences of AKI, infection and thromboembolism were 44.4%, 25.6% and 12.2%, respectively. Patients with AKI were more likely to be male, with lower serum albumin, greater proteinuria and more severe acute tubulointerstitial damage. Patients with infection had higher proteinuria and lower serum albumin, globulin and IgG. Circulating endothelial cells (CECs) and von Willebrand factor were higher in patients with thromboembolism. Logistic regression showed that increased urine retinol-binding protein, decreased serum albumin and IgG, and increased CECs and hemoglobin were independent risk factors for AKI, infection and thromboembolism, respectively.
CONCLUSIONS: AKI, infection and thromboembolism are common among FSGS patients. Awareness of risk factors and prevention of these complications are important for the prognosis of these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22009935     DOI: 10.5301/jn.5000040

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  4 in total

Review 1.  Bone Health in Glomerular Kidney Disease.

Authors:  Dorey A Glenn; Michelle R Denburg
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

2.  Vitamin D supplementation in children and young adults with persistent proteinuria secondary to glomerular disease.

Authors:  Amy J Kogon; Lance S Ballester; Jarcy Zee; Natalie Walker; Joshua J Zaritsky; Meredith A Atkinson; Christine B Sethna; Andrew N Hoofnagle; Mary B Leonard; Michelle R Denburg
Journal:  Pediatr Nephrol       Date:  2022-07-19       Impact factor: 3.651

3.  Strategy and rationale for urine collection protocols employed in the NEPTUNE study.

Authors:  Marie C Hogan; John C Lieske; Chrysta C Lienczewski; Lisa L Nesbitt; Larysa T Wickman; Christina M Heyer; Peter C Harris; Christopher J Ward; Jamie L Sundsbak; Luca Manganelli; Wenjun Ju; Jeffrey B Kopp; Peter J Nelson; Sharon G Adler; Heather N Reich; Lawrence B Holzmann; Matthias Kretzler; Markus Bitzer
Journal:  BMC Nephrol       Date:  2015-11-17       Impact factor: 2.388

4.  miR-217 Is a Useful Diagnostic Biomarker and Regulates Human Podocyte Cells Apoptosis via Targeting TNFSF11 in Membranous Nephropathy.

Authors:  Jing Li; Bin Liu; Hen Xue; Qiao Qiao Zhou; Ling Peng
Journal:  Biomed Res Int       Date:  2017-10-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.